Akèy › Kolestewòl › Kalifòni
Etid klinik pou Kolestewòl nan Kalifòni
6 etid pou Kolestewòl ap chèche patisipan nan sit nan Kalifòni.
Tèks ofisyèl etid la (Anglè)
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- Pacific Oaks Medical Group, Beverly Hills
- Cardiovascular Institute of San Diego, Chula Vista
- John Muir Medical Center - Concord Campus, Concord
- ak 10 plis
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06909565A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.
- Research Site, Huntington Beach
- Research Site, Loma Linda
- Research Site, Lomita
- ak 2 plis
Ap rekriteFaz 3
Laj 18 a 130 · Tout sèks · Mizajou Sep 10, 2026 · NCT07619131A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
- Clinical Trials Research, Lincoln
- Downtown L A Research Center Inc, Los Angeles
- Valley Clinical Trials, Northridge
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Jul 30, 2026 · NCT07610278Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
- UC San Francisco Medical Center, San Francisco
Ap rekriteFaz 3
Laj 2 a 11 · Tout sèks · Mizajou Jul 24, 2026 · NCT06597006A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
- Anaheim Clinical Trials, Anaheim
- Cenexel CNS, Los Alamitos
- Diablo Clinical Research - Flourish Research, Walnut Creek
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Jul 22, 2026 · NCT07477704Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
- UC San Francisco Medical Center, San Francisco
- UC San Francisco Medical Center, San Francisco
Ap rekriteFaz 3
Laj 6 a 11 · Tout sèks · Mizajou May 15, 2026 · NCT06597019Sous ClinicalTrials.gov, done yo ranmase Oct 3, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.